Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (131-140 of 544) with videos related to

Pageof 55
Sort By:
The Breast Journal|September 25, 2009
Family information service participation increases the rates of mutation testing among members of families with BRCA1/2 mutationsHenry T Lynch, Carrie L Snyder, Jane F Lynch, et al.
Breast Cancer Research and Treatment|August 19, 2020
Association of RAD51C germline mutations with breast cancer among BahamiansMaryam Bagherzadeh, Agata Szymiczek, Talia Donenberg, et al.
Cancers|April 30, 2021
The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in CanadaSteven A Narod, Nicole Gojska, Ping Sun, et al.
Cancer Treatment Reviews|July 22, 2011
Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic reviewJavaid Iqbal, Ophira M Ginsburg, Thiwanka D Wijeratne, et al.
American Journal of Human Genetics|August 16, 2002
Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in PakistanAlexander Liede, Imtiaz A Malik, Zeba Aziz, et al.
Gynecologic Oncology|November 12, 2018
Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutationElizabeth Hall, Amy Finch, Michelle Jacobson, et al.
Carcinogenesis|April 17, 2007
Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen useWilliam Chu, Anthony Fyles, Edward M Sellers, et al.
Hereditary Cancer in Clinical Practice|June 13, 2023
Genetic testing for hereditary breast cancer in Poland: 1998-2022Jacek Gronwald, Cezary Cybulski, Tomasz Huzarski, et al.
Bone Reports|September 19, 2024
Delineating the relationship between circulating osteoprotegerin and bone health in women with a pathogenic variant in <i>BRCA1</i>: A cross-sectional analysisAghaghia Mokhber, Elizabeth Hall, Aleksandra Uzelac, et al.
Plos One|February 10, 2017
Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancerYaron Kinar, Pinchas Akiva, Eran Choman, et al.
Pageof 55

Showing results (131-140 of 544) with videos related to

Sort By:
Pageof 55
The Breast Journal|September 25, 2009
Family information service participation increases the rates of mutation testing among members of families with BRCA1/2 mutationsHenry T Lynch, Carrie L Snyder, Jane F Lynch, et al.
Breast Cancer Research and Treatment|August 19, 2020
Association of RAD51C germline mutations with breast cancer among BahamiansMaryam Bagherzadeh, Agata Szymiczek, Talia Donenberg, et al.
Cancers|April 30, 2021
The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in CanadaSteven A Narod, Nicole Gojska, Ping Sun, et al.
Cancer Treatment Reviews|July 22, 2011
Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic reviewJavaid Iqbal, Ophira M Ginsburg, Thiwanka D Wijeratne, et al.
American Journal of Human Genetics|August 16, 2002
Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in PakistanAlexander Liede, Imtiaz A Malik, Zeba Aziz, et al.
Gynecologic Oncology|November 12, 2018
Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutationElizabeth Hall, Amy Finch, Michelle Jacobson, et al.
Carcinogenesis|April 17, 2007
Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen useWilliam Chu, Anthony Fyles, Edward M Sellers, et al.
Hereditary Cancer in Clinical Practice|June 13, 2023
Genetic testing for hereditary breast cancer in Poland: 1998-2022Jacek Gronwald, Cezary Cybulski, Tomasz Huzarski, et al.
Bone Reports|September 19, 2024
Delineating the relationship between circulating osteoprotegerin and bone health in women with a pathogenic variant in <i>BRCA1</i>: A cross-sectional analysisAghaghia Mokhber, Elizabeth Hall, Aleksandra Uzelac, et al.
Plos One|February 10, 2017
Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancerYaron Kinar, Pinchas Akiva, Eran Choman, et al.
Pageof 55